文献速递头颈部肿瘤放疗

老年鼻咽癌患者总生存预后模型:递归分区分析识别治疗前风险分层

Prognostic model on overall survival in elderly nasopharyngeal carcinoma patients: a recursive partitioning analysis identifying pre-treatment risk stratification.
PubMed 文献 · Radiat Oncol · 2023-06-23

该研究纳入2015至2019年诊断的283例老年鼻咽癌患者,以总生存为主要终点,采用Cox回归和递归分区分析进行风险分层并构建预后指数。中危组(I-III期且治疗前EBV>1840拷贝/ml)和高危组(IVA期)中,诱导化疗后放疗与诱导化疗联合同期放化疗的总生存相似;低危组(I-III期且治疗前EBV≤1840拷贝/ml)单纯调强放疗可能为最佳选择。预后指数对1年、3年、5年总生存预测的AUC分别为0.75、0.80、0.82。

要点

  • 中危组(I-III期且EBV>1840拷贝/ml)和高危组(IVA期)中,诱导化疗后放疗与诱导化疗联合同期放化疗的总生存相似。
  • 低危组(I-III期且EBV≤1840拷贝/ml)单纯调强放疗可能为最佳治疗选择。
  • 预后指数对1年、3年、5年总生存预测的AUC分别为0.75、0.80、0.82。

核心结论

  • 本研究提出的临床分层模型可指导老年鼻咽癌患者的个体化治疗。

研究设计与样本

  • 研究纳入2015至2019年诊断的283例老年鼻咽癌患者,以总生存为主要终点。
  • 采用单因素和多因素Cox回归分析识别预后因素,递归分区分析进行风险分层,并构建预后指数。

主要发现

  • 基于递归分区分析的风险分层显示,中危组(I-III期且治疗前EBV>1840拷贝/ml)和高危组(IVA期)中,诱导化疗后放疗与诱导化疗联合同期放化疗的总生存相似。
  • 低危组(I-III期且治疗前EBV≤1840拷贝/ml)中,单纯调强放疗可能为最佳治疗选择。
  • 预后指数对1年、3年、5年总生存预测的AUC分别为0.75、0.80、0.82,预测效能强于单一因素。

关键数值与推荐

  • 风险分层标准:低危组为I-III期且治疗前EBV≤1840拷贝/ml;中危组为I-III期且治疗前EBV>1840拷贝/ml;高危组为IVA期。
  • 预后指数预测1年、3年、5年总生存的AUC分别为0.75、0.80、0.82。

临床怎么用

  • 作者认为,中危组和高危组老年鼻咽癌患者中诱导化疗后放疗与诱导化疗联合同期放化疗的总生存相似。
  • 作者认为,低危组老年鼻咽癌患者中单纯调强放疗可能为最佳治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to evaluate the optimal management for elderly patients with nasopharyngeal carcinoma (NPC) with intensity-modulated radiotherapy (IMRT). METHODS: A total of 283 elderly patients with NPC diagnosed from 2015 to 2019 were enrolled in the study. Overall survival (OS) was the primary endpoint. Univariate and multivariate Cox regression analyses were preformed to identify potential prognostic factors. The recursive partitioning analysis (RPA) was used for risk stratification. Kaplan-Meier survival curves were applied to evaluate the survival endpoints, and log-rank test was utilized to assess differences between groups. The prognostic index (PI) was constructed to further predict patients' prognosis displayed by nomogram model. The area under the receiver operating characteristic (ROC) curves (AUC) and the calibration curves were applied to assess the effectiveness of the model. RESULTS: Based on RPA-based risk stratification, we demonstrated that elderly NPC patients who were treated with IC followed by RT had similar OS as those with induction chemotherapy (IC) combined with concurrent chemoradiotherapy (CCRT) in the middle- (stage I-III and pre-treatment EBV > 1840 copies/ml) and high-risk groups (stage IVA). IMRT alone may be the optimal treatment option for the low-risk group (stage I-III with pre-treatment EBV ≤ 1840 copies/ml). We established an integrated PI which was indicted with stronger prognostic power than each of the factors alone for elderly NPC patients (The AUC of PI was 0.75, 0.80, and 0.82 for 1-, 3-, 5-year prediction of OS, respectively). CONCLUSION: We present a robust model for clinical stratification which could guide individual therapy for elderly NPC patients.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Li Y, Weng Y, Huang Z, et al. Prognostic model on overall survival in elderly nasopharyngeal carcinoma patients: a recursive partitioning analysis identifying pre-treatment risk stratification. Radiat Oncol. 2023. PMID: 37353800. doi:10.1186/s13014-023-02272-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。